Factors Affecting Adherence to Statins in Hypercholesterolemic Kuwaiti Patients: A Cross-Sectional Study

Medical Principles and Practice

Volumn 26, Issue 1, 2017, Pages 35-40

  Al Foraih, Meisa ^a   Somerset, Shawn ^b  

^a MANUFACTURING ENGINEERING DEPARTMENT   (Kuwait)

^b AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

Author keywords

Adherence; Hypercholesterolemia; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION ANXIETY STRESS SCALE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; KUWAITI; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICATION COMPLIANCE; MIDDLE AGED; PRIMARY HEALTH CARE; AGE DISTRIBUTION; BLOOD; COMORBIDITY; DIABETES MELLITUS; HYPERTENSION; INTERVIEW; KUWAIT; MENTAL DISORDERS; PSYCHOLOGY; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGED; CHOLESTEROL; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVIEWS AS TOPIC; KUWAIT; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 84986576651     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000450644     Document Type: Article

References (30)

1. Gaziano TA, Bitton A, Anand S, et al: Growing epidemic of coronary heart disease in lowand middle-income countries. Curr Probl Cardiol 2010; 35: 72-115
2. Awad AI, Alsaleh FM: 10-Year Risk estimation for type 2 diabetes mellitus and coronary heart disease in Kuwait: a cross-sectional population-based study. PLoS One 2015; 10:e0116742
3. Elshourbagy NA, Meyers HV, Abdel-Meguid SS: Cholesterol: the good, the bad, and the ugly-therapeutic targets for the treatment of dyslipidemia. Med Princ Pract 2013; 23: 99-111
4. Mann DM, Woodward M, Muntner P, et al: Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother 2010; 44: 1410-1421
5. Brown MT, Bussell JK: Medication adherence: WHO cares? Mayo Clin Proc 2011; 86: 304-314
6. Liberopoulos EN, Florentin M, Mikhailidis DP, et al: Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin 2008; 7: 717-725
7. Pedan A, Varasteh LT, Schneeweiss S: Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm 2007; 13: 487-496
8. Yilmaz MB, Pinar M, Naharci I, et al: Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther 2005; 19: 437-440
9. Al Sifri SN, Almahmeed W, Azar S, et al: Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment. PLoS One 2014; 9:e84350
10. Green SB: How many subjects does it take to do a regression analysis. Multivariate Behav Res 1991; 26: 499-510
11. Al-Isa A: Temporal changes in body mass index and prevalence of obesity among Kuwaiti men. Ann Nutr Metab 1997; 41: 307-314
12. Bu-Olayan A, Thomas B: Dispersion model on PM 2.5 fugitive dust and trace metal levels in Kuwait governorates. Environ Monit Assess 2012; 184: 1731-1737
13. Grover SA, Abrahamowicz M, Joseph L, et al: The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity. JAMA 1992; 267: 816-822
14. Crawford JR, Henry JD: The depression anxiety stress scale (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003; 42: 111-131
15. Lovibond SH, Lovibond PF: Manual for the Depression, Anxiety, Stress Scales. Sydney, Psychology Foundation, 1995
16. Morisky DE, Ang A, Krousel-Wood M, et al: Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens 2008; 10: 348-354
17. Ihmels M, Welk GJ, McClain JJ, et al: The reliability and convergent validity of field tests of body composition in young adolescents. J Phys Act Health 2006; 3: 67-77
18. Bosy-Westphal A, Later W, Hitze W, et al: Accuracy of bioelectrical impedance consumer devices for measurement of body composition in comparison to whole body magnetic resonance imaging and dual X-ray absorptiometry. Obes Facts 2008; 1: 319-324
19. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359
20. Lakka H-M, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716
21. Grubb NR, Newby DE: Churchill's Pocketbook of Cardiology. Edinburgh, Churchill Livingstone, 2006
22. STATA statistical software: release 11. College Station, StataCorp, 2009
23. Hosmer DW, Lemeshow S, May S: Applied survival analysis; in: Wiley Series in Probability and Statistics. Hoboken, Wiley, 2008
24. Natarajan N, Putnam RW, Yip AM, et al: Family practice patients' adherence to statin medications. Can Fam Physician 2007; 53: 2144-2145
25. Cutler DM, Jan S, Fischer MA, et al: Patient, Physician, and Payment Predictors of Statin Adherence. Cambridge, Harvard University Department of Economics, 2010
26. Latry P, Molimard M, Dedieu B, et al: Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovasc Disord 2011; 11: 46
27. Ziegelstein RC, Howard B: Depression and poor adherence to lipid-lowering medications among patients with coronary artery disease. J Psychosom Res 2010; 69: 175-177
28. Weilburg JB, O'Leary KM, Grant RW: Impact of antidepressant therapy on statin adherence and cholesterol control. Am J Pharm 2009; 1: 158-163
29. Sulaiman N, Hamdan A, Tamim H, et al: The prevalence and correlates of depression and anxiety in a sample of diabetic patients in Sharjah, United Arab Emirates. BMC Fam Pract 2010; 11: 80-86
30. Somerset SM, Graham L, Markwell KE: Depression scores predict adherence in a dietary weight loss intervention trial. Clin Nutr 2011; 30: 593-598